Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Phosphorylation of serine 1106 in the catalytic domain of topoisomerase II alpha regulates enzymatic activity and drug sensitivity.

Chikamori K, Grabowski DR, Kinter M, Willard BB, Yadav S, Aebersold RH, Bukowski RM, Hickson ID, Andersen AH, Ganapathi R, Ganapathi MK.

J Biol Chem. 2003 Apr 11;278(15):12696-702. Epub 2003 Feb 4.

2.
3.

Regulation of topoisomerase II by phosphorylation: a role for casein kinase II.

Cardenas ME, Gasser SM.

J Cell Sci. 1993 Feb;104 ( Pt 2):219-25. Review. No abstract available.

4.

Cytotoxic signalling by inhibitors of DNA topoisomerase II.

Beck WT, Mo YY, Bhat UG.

Biochem Soc Trans. 2001 Nov;29(Pt 6):702-3. Review.

PMID:
11709058
5.

Casein kinase I and II--multipotential serine protein kinases: structure, function, and regulation.

Tuazon PT, Traugh JA.

Adv Second Messenger Phosphoprotein Res. 1991;23:123-64. Review. No abstract available.

PMID:
1997039
6.

[Protein kinase CKII].

Wojda I.

Postepy Biochem. 2000;46(2):148-53. Review. Polish. No abstract available.

PMID:
11059001
7.

Topoisomerase II: its functions and phosphorylation.

Gasser SM, Walter R, Dang Q, Cardenas ME.

Antonie Van Leeuwenhoek. 1992 Aug;62(1-2):15-24. Review.

PMID:
1332607
8.

[Studies on molecular mechanism of toxicity of anticancer drugs].

Takahashi T.

Yakugaku Zasshi. 2011 Mar;131(3):355-8. Review. Japanese.

Supplemental Content

Support Center